ÂÜÀòÂÒÂ×

Kevin Slawin, MD., is the Founder and Managing Partner of Rapha Capital Management, LLC. He is a successful and experienced oncologic and robotic surgeon, biotech consultant, investor, and founder focusing on breakthrough healthcare technologies. He is the founder of Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) and the Vanguard Urologic Institute at Memorial Hermann Medical Group in Houston, Texas, where he was also the Director of Urology at Memorial Hermann Hospital. Slawin graduated, magna cum laude, with a Bachelor of Arts degree in Biochemistry from Columbia University, and earned his medical degree in 1986 from Columbia College of Physicians and Surgeons, and was elected to the Alpha Omega Alpha honor society.